Skip to main content
logo
Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
0.3858
+0.0107 (2.85%)
At close: Aug 7, 2026, 4:00 PM EDT
0.3806
-0.0052 (-1.35%)
After-hours: Aug 7, 2026, 7:34 PM EDT

Immutep Revenue

Immutep had revenue of 4.10M AUD in the half year ending December 31, 2025, with 4,506.78% growth. This brings the company's revenue in the last twelve months to 4.13M, up 7,650.57% year-over-year. In the fiscal year ending June 30, 2025, Immutep had annual revenue of 59.71K, down -49.86%.

Revenue (ttm)
4.13M AUD
Revenue Growth
+7,650.57%
P/S Ratio
9.45
Revenue / Employee
133,292 AUD
Employees
31
Market Cap
49.96M USD

Revenue Chart

Chart
* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202559.71K-59.38K-49.86%
Jun 30, 2024119.09K-72.63K-37.88%
Jun 30, 2023191.72K-62.67K-24.63%
Jun 30, 2022254.39K-58.45K-18.68%
Jun 30, 2021312.84K-7.45M-95.97%
Jun 30, 20207.77M6.47M499.78%
Jun 30, 20191.29M-2.34M-64.42%
Jun 30, 20183.64M2.84M354.63%
Jun 30, 2017800.46K625.41K357.27%
Jun 30, 2016175.05K--
Jun 30, 2015---
Jun 30, 2014---
Jun 30, 2013---
Jun 30, 2012---
Jun 30, 2011---
Jun 30, 2010---
Jun 30, 2009---
Jun 30, 2008---
Jun 30, 2007---
Jun 30, 2006---
Jun 30, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Karyopharm Therapeutics151.12M
TScan Therapeutics9.14M
Seres Therapeutics1.88M
RenovoRx1.49M
Mereo BioPharma Group500.00K
aTyr Pharma190.00K
Impact BioMedical35.00K
Revenue Rankings

IMMP News

More News